Mineralys Therapeutics (MLYS) filed an 8-K saying it had issued a press release on August 11, 2026 with its financial results for the quarter ended June 30, 2026 and a corporate update. The press release is attached as an exhibit. The filing is dated August 5, 2026, even though the press release is dated later, and the excerpt doesn't include any actual revenue or profit numbers, nor any executive changes. There is also a 5.02 item listed on the form, but the excerpt gives no details about it.
View Full Filing (SEC EDGAR)